Vacuum-assisted Biopsy Devices Market Size, Share, Competitive Landscape and Trend Analysis Report, by Product, by Type, by Technique, by Application, by End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

Key Market Dynamics

Accordig to Vacuum-assisted biopsy devices market analysis, key factors driving vacuum-assisted biopsy devices market growth are rising incidence of cancer, technological advancements in cancer diagnostic, preference for minimally invasive procedures, and advantages over traditional biopsy methods.  The rising incidence of cancer has emerged as a significant catalyst propelling the vacuum-assisted biopsy devices market. According to an article by World Health Organization, in 2022, there were 2.3 million women diagnosed with breast cancer globally. As cancer rates continue to escalate globally, there's an increasing demand for more accurate and minimally invasive diagnostic techniques. Vacuum-assisted biopsy devices offer a sophisticated solution, allowing for precise sampling of tissues with minimal patient discomfort and reduced risk of complications. This technology enables clinicians to obtain larger tissue samples compared to traditional biopsy methods, thereby improving the accuracy of cancer diagnosis and subsequent treatment planning. Thus, the rising incidence of cancer globally and technological advancemnt in the vacuum-assisted biopsy devices is expected to drive the vacuum-assisted biopsy devices market growth.

Furthermore, according to the vacuum-assisted biopsy devices market forecast analysis the rise in demand for minimally invasive procedures is expected to drive the growth of the market. The growing preference towards the minimally invasive procedures is owing to reduced patient discomfort, shorter recovery times, and lower risks of complications compared to traditional surgical methods. Minimally invasive procedures typically involve smaller incisions or entry points, leading to less tissue trauma and scarring. Vacuum-assisted biopsy devices allow clinicians to collect larger tissue samples with greater precision and control, thereby enhancing diagnostic accuracy while minimizing patient discomfort. Moreover, the ability to perform biopsies using vacuum assistance often enables clinicians to target lesions more effectively, especially in challenging anatomical locations. Thus, the rise in preference towards minimally invasive procedures is expected to drive the growth of the vacuum-assisted biopsy devices market size.

Top 10 Cancer by Type

The top ten types of cancer, listed by their prevalence, highlight a significant health burden worldwide. Breast cancer is the most common, accounting for 12.5% of cases. It is closely followed by lung cancer, which constitutes 12.2% of cases. Colorectal cancer is the third most prevalent, with 10.7% of cases. Prostate cancer, primarily affecting men, represents 7.8% of cancer diagnoses. Stomach cancer is also notable, comprising 6% of cases, while liver cancer makes up 5%. Both cervix uterine cancer and oesophageal cancer each account for 3.3% of cases, indicating a considerable impact on the global population. Thyroid and bladder cancers each have a prevalence of 3.2%.  Accordig to vacuum-assisted biopsy devices market trends analysis, as cancer rates increase globally, there is a growing demand for effective diagnostic tools that can accurately detect and characterize suspicious lesions. Vacuum-assisted biopsy devices have emerged as an efficient diagnostic option, offering advantages over traditional biopsy methods such as core needle biopsy. Vacuum-assisted biopsy devices allow for more precise targeting of tissue samples, minimizing the need for repeated procedures and reducing patient discomfort. Moreover, vacuum-assisted biopsy devices enable clinicians to obtain larger tissue samples, which can improve diagnostic accuracy and facilitate molecular testing for personalized treatment approaches.

Market Segmentation

The vacuum-assisted biopsy devices industry is segmented into by product, type, technique, applications, end user, and region. By product, the market is divided into vacuum-assisted biopsy systems and vacuum-assisted biopsy needles. By type, the market is divided into 9-12G, <9G, >12G. By technique, the market is divided into ultrasound-guided biopsy, stereotactic, guided biopsy, MRI-guided biopsy, and others.  As per application, the market is divided into breast biopsy, lung biopsy, colorectal biopsy, prostate biopsy, and others. By end users, the market is divided into hospitals, academic and research institutes, diagnostic and imaging centers, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Regional/Country Market Outlook

North America dominated the vacuum-assisted biopsy devices market share owing to high prevalence of cancer, a robust healthcare infrastructure, significant investments in research and development, and strong presence of major key players. Hoever, according to vacuum-assisted biopsy devices market opportunity analysis the Asia-Pacific region is witnessing rapid growth, propelled by increasing healthcare expenditure, a rising geriatric population, and growing awareness of cancer.

• In a 2024 article published by National Centre for Disease Informatics and Research, it was estimated that the projected cancer burden in India is expected to rise from 26.7 million DALYs (Disability-adjusted life year) in 2021 to 29.8 million in 2025. 
• According to 2024 article by National Breast Cancer Foundation, Inc, in 2024, an estimated 310, 720 women and 2, 800 men will be diagnosed with invasive breast cancer.
• In an article published by European Commission, it was reported that in 2021, cancer was the second leading cause of death in the Europe, with 1.1 million deaths

Industry Trends

• In a 2023 article published by National Library of Medicine, it was reported that vacuum-assisted biopsy system offers valuable insights to optimize patients’ surgical options and decrease the incidence of malignant outcomes.
• In a 2021 article published by National Library of Medicine it was reported that vacuum-assisted breast biopsy is a safe and efficient procedure for the diagnosis and management of indeterminate and suspicious breast lesions.
• In January 2023, vacuum-assisted breast biopsy and excision technology that has been used at Sri Ramachandra Medical Centre has helped remove benign breast tumors without any surgery in a day care procedure. It has also greatly improved accurate diagnosis for cancer compared to the widely used traditional core needle biopsy.

Competitive Landscape

The major players operating in the vacuum-assisted biopsy devices market include Becton, Dickinson and Company, Cook Medical, Devicor Medical Products, Inc., Argon Medical., B. Braun Melsungen AG, Cardinal Health, Olympus Corporation, Boston Scientific Corporation, Medtronic Plc, and Inrad Inc. 
Other players in vacuum-assisted biopsy devices market includes Fujifilm Corporation, and Hologic, Inc.

Recent Key Strategies and Developments

• In February 2021, Medtronic announced the launch of the Achieve Advanced Enabling Technology for its Achieve Advanced Steerable Sheath. This technology provides enhanced control and access during vacuum-assisted biopsy procedures.
• In June 2022, Medtronic Plc received FDA 510 (k) clearance and CE Mark approval for the integration of advanced INVOS regional oximetry and Micro stream capnography technologies on the CARESCAPE precision monitoring platform. Micro stream capnography (CO2) technology captures evolving respiratory compromise, while INVOSTM regional oximetry (rSO2) technology helps clinicians predict and prevent perioperative complications faster than traditional peripheral measurement.
• In March 2021, IZI Medical Products, LLC launched The Quick-Core Auto Biopsy System ("Quick-Core Auto") for soft tissue biopsy. Quick-Core Auto is a lightweight, fully automatic biopsy system that offers the precision, dependability, and quality of IZI's Quick-Core semi-automatic biopsy system

Key Sources Referred

1. World Health Organization
2. Cancer Research UK
3. Center of Disease Control and Prevention
4. National Library of Medicine
5. American Cancer Society
6. Indian Cancer Society
7. European Cancer Organization

Key Benefits for Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the vacuum-assisted biopsy devices market  analysis from 2024 to 2033 to identify the prevailing vacuum-assisted biopsy devices market  opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the vacuum-assisted biopsy devices market  segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global vacuum-assisted biopsy devices market  trends, key players, market segments, application areas, and market growth strategies.